Erratum: Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456793/
https://www.ncbi.nlm.nih.gov/pubmed/28157683
http://dx.doi.org/10.1136/gutjnl-2016-312444corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456793/
https://www.ncbi.nlm.nih.gov/pubmed/28157683
http://dx.doi.org/10.1136/gutjnl-2016-312444corr1

Ejemplares similares